[1] N. L. Trevaskis, L. M. Kaminskas, C. J. H. Porter. From sewer to saviour — targeting the lymphatic system to promote drug exposure and activity. Nat. Rev. Drug Discov., 14, 781-803(2015).

[2] D. Li, S. Liu, T. Yu, Z. Liu, S. Sun, D. Bragin, A. Shirokov, N. Navolokin, O. Bragina, Z. Hu, J. Kurths, I. Fedosov, I. Blokhina, A. Dubrovski, A. Khorovodov, A. Terskov, M. Tzoy, O. Semyachkina-Glushkovskaya, D. Zhu. Photostimulation of brain lymphatics in male newborn and adult rodents for therapy of intraventricular hemorrhage. Nat. Commun., 14, 6104(2023).

[3] A. F. M. Salvador, N. Abduljawad, J. Kipnis. Meningeal lymphatics in central nervous system diseases. Annu. Rev. Neurosci., 47, 323-344(2024).

[4] S. Da Mesquita, Z. Papadopoulos, T. Dykstra, L. Brase, F. G. Farias, M. Wall, H. Jiang, C. D. Kodira, K. A. de Lima, J. Herz, A. Louveau, D. H. Goldman, A. F. Salvador, S. Onengut-Gumuscu, E. Farber, N. Dabhi, T. Kennedy, M. G. Milam, W. Baker, I. Smirnov, S. S. Rich, B. A. Benitez, C. M. Karch, R. J. Perrin, M. Farlow, J. P. Chhatwal, D. M. Holtzman, C. Cruchaga, O. Harari, J. Kipnis. Meningeal lymphatics modulate microglial activation and immunotherapy in Alzheimer’s disease. Nature, 593, 255-260(2021).

[5] M. Wang, C. Yan, X. Li, T. Yang, S. Wu, Q. Liu, Q. Luo, F. Zhou. Non-invasive modulation of meningeal lymphatics ameliorates ageing and Alzheimer’s disease-associated pathology and cognition in mice. Nat. Commun., 15, 1453(2024).

[6] F. Di Virgilio, D. Dal Ben, A. C. Sarti, A. L. Giuliani, S. Falzoni. The P2X7 receptor in infection and inflammation. Immunity, 47, 15-31(2017).

[7] F. Calzaferri, C. Ruizirri”nilianiarti, A. L. GiulianiPascual, I. M I. alLópez, M. F. Canoi”nilianiaManeu, C. de los Ríos, L. Gandía, A. G. García. The purinergic P2X7 receptor as a potential drug target to combat neuroinflammation in neurodegenerative diseases. Med. Res. Rev., 40, 2427-2465(2020).

[8] M. Tewari, P. Seth. Emerging role of P2X7 receptors in CNS health and disease. Ageing Res. Rev., 24, 328-342(2015).

[9] X.-H. Wang, X. Xie, X.-G. Luo, H. Shang, Z.-Y. He. Inhibiting purinergic P2X7 receptors with the antagonist brilliant blue G is neuroprotective in an intranigral lipopolysaccharide animal model of Parkinson’s disease. Mol. Med. Rep., 15, 768-776(2017).

[10] S. Merighi, T. E. Poloni, A. Terrazzan, E. Moretti, S. Gessi, D. Ferrari. Alzheimer and purinergic signaling: Just a matter of inflammation?. Cells, 10, 1267(2021).

[11] Y.-H. Chen, R.-R. Lin, Q.-Q. Tao. The role of P2X7R in neuroinflammation and implications in Alzheimer’s disease. Life Sci., 271, 119187(2021).

[12] H. Dong, X. Dai, Y. Zhou, C. Shi, P. Bhuiyan, Z. Sun, N. Li, W. Jin. Enhanced meningeal lymphatic drainage ameliorates lipopolysaccharide-induced brain injury in aged mice. J. Neuroinflammation, 21, 36(2024).

[13] L. E. B. Savio, M. G. J. Andrade, P. de Andrade Mello, P. T. Santana, A. C. A. Moreira-Souza, J. Kolling, A. Longoni, L. Feldbrügge, Y. Wu, A. T. S. Wyse, S. C. Robson, R. Coutinho-Silva. P2X7 receptor signaling contributes to sepsis-associated brain dysfunction. Mol. Neurobiol., 54, 6459-6470(2016).

[14] Z. Fan, K. Wang, X. Zhao, X. Sun. P2X7 receptor: A receptor closely linked with sepsis-associated encephalopathy. Open Life Sci., 19, 20220775(2024).

[15] M. Sidoryk-Wegrzynowicz, L. Struzynska. Astroglial and microglial purinergic P2X7 receptor as a major contributor to neuroinflammation during the course of multiple sclerosis. Int. J. Mol. Sci., 22, 8404(2021).

[16] B. Sridharan, H. G. Lim. Advances in photoacoustic imaging aided by nano contrast agents: Special focus on role of lymphatic system imaging for cancer theranostics. J. Nanobiotechnol., 21, 437(2023).

[17] Z. Wang, F. Yang, W. Shi, W. Xie, Z. Zhang, S. Yang. Monitoring the perivascular cerebrospinal fluid dynamics of the glymphatic pathway using co-localized photoacoustic microscopy. Opt. Lett., 48, 2265-2268(2023).

[18] Y. Suzuki, H. Kajita, N. Konishi, A. Oh, M. Urano, S. Watanabe, Y. Asao, N. Imanishi, T. Tsuji, M. Jinzaki, S. Aiso, K. Kishi. Subcutaneous lymphatic vessels in the lower extremities: Comparison between photoacoustic lymphangiography and near-infrared fluorescence lymphangiography. Radiology, 295, 469-474(2020).

[19] F. Yang, Z. Wang, W. Shi, M. Wang, R. Ma, W. Zhang, X. Li, E. Wang, W. Xie, Z. Zhang, Q. Shen, F. Zhou, S. Yang. Advancing insights into in vivo meningeal lymphatic vessels with stereoscopic wide-field photoacoustic microscopy. Light Sci. Appl., 13, 96(2024).

[20] Z. Wang, F. Yang, W. Zhang, K. Xiong, S. Yang. Towards in vivo photoacoustic human imaging: Shining a new light on clinical diagnostics. Fundam. Res., 4, 1314-1330(2024).

[21] X. Li, Z. Zhang, H. Shi, F. Zhou. Characterization of cerebrovascular changes in Alzheimer’s disease mice by photoacoustic imaging. J. Innov. Opt. Health Sci., 17, 2450007(2024).

[22] W. Zhang, X. Luo, F. Yang, Z. Tong, J. Liang, B. Yuan, S. Yang, Z. Wang. Photoacoustic (532 and 1064 nm) and ultrasonic coscanning microscopy for in vivo imaging on small animals: A productized strategy. J. Biophotonics, 16, e202300007(2023).

[23] X. Li, L. Qi, D. Yang, S. Hao, F. Zhang, X. Zhu, Y. Sun, C. Chen, J. Ye, J. Yang, L. Zhao, D. M. Altmann, S. Cao, H. Wang, B. Wei. Meningeal lymphatic vessels mediate neurotropic viral drainage from the central nervous system. Nat. Neurosci., 25, 577-587(2022).

[24] X. Hu, Q. Deng, L. Ma, Q. Li, Y. Chen, Y. Liao, F. Zhou, C. Zhang, L. Shao, J. Feng, T. He, W. Ning, Y. Kong, Y. Huo, A. He, B. Liu, J. Zhang, R. Adams, Y. He, F. Tang, X. Bian, J. Luo. Meningeal lymphatic vessels regulate brain tumor drainage and immunity. Cell Res., 30, 229-243(2020).

[25] B.-L. Sun, L.-H. Wang, T. Yang, J.-Y. Sun, L.-L. Mao, M.-F. Yang, H. Yuan, R. A. Colvin, X.-Y. Yang. Lymphatic drainage system of the brain: A novel target for intervention of neurological diseases. Prog. Neurobiol., 164, 118-143(2018).

[26] J. Liao, Z. An, Q. Cheng, Y. Liu, Y. Chen, Z. Su, A. M. Usman, Z. Tang, G. Xiao. The glymphatic system: A new insight into the understanding of neurological diseases. Brain-X, 2, e70011(2024).

[27] S. Da Mesquita, A. Louveau, A. Vaccari, I. Smirnov, R. C. Cornelison, K. M. Kingsmore, C. Contarino, S. Onengut-Gumuscu, E. Farber, D. Raper, K. E. Viar, R. D. Powell, W. Baker, N. Dabhi, R. Bai, R. Cao, S. Hu, S. S. Rich, J. M. Munson, M. B. Lopes, C. C. Overall, S. T. Acton, J. Kipnis. Functional aspects of meningeal lymphatics in ageing and Alzheimer’s disease. Nature, 560, 185-191(2018).

[28] M. K. Rasmussen, H. Mestre, M. Nedergaard. The glymphatic pathway in neurological disorders. Lancet Neurol., 17, 1016-1024(2018).

[29] J. H. Ahn, H. Cho, J. H. Kim, S. H. Kim, J. S. Ham, I. Park, S. H. Suh, S. P. Hong, J. H. Song, Y. K. Hong, Y. Jeong, S. H. Park, G. Y. Koh. Meningeal lymphatic vessels at the skull base drain cerebrospinal fluid. Nature, 572, 62-66(2019).

[30] K. Zou, Q. Deng, H. Zhang, C. Huang. Glymphatic system: A gateway for neuroinflammation. Neural Regen. Res., 19, 2661-2672(2024).

[31] M. A. Erickson, P. E. Hartvigson, Y. Morofuji, J. B. Owen, D. A. Butterfield, W. A. Banks. Lipopolysaccharide impairs amyloid beta efflux from brain: Altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood-brain barrier. J. Neuroinflammation, 9, 150(2012).

[32] H. Zhao, X. Zhang, Z. Dai, Y. Feng, Q. Li, J. H. Zhang, X. Liu, Y. Chen, H. Feng. P2X7 receptor suppression preserves blood-brain barrier through inhibiting RhoA activation after experimental intracerebral hemorrhage in rats. Sci. Rep., 6, 23286(2016).

[33] M. Akhtari, S. J. Zargar, M. Vojdanian, A. Jamshidi, M. Mahmoudi. Monocyte-derived and M1 macrophages from ankylosing spondylitis patients released higher TNF-alpha and expressed more IL1B in response to BzATP than macrophages from healthy subjects. Sci. Rep., 11, 17842(2021).

[34] W. Sun, Q. Wang, R. Zhang, N. Zhang. Ketogenic diet attenuates neuroinflammation and induces conversion of M1 microglia to M2 in an EAE model of multiple sclerosis by regulating the NF-kappaB/NLRP3 pathway and inhibiting HDAC3 and P2X7R activation. Food Funct., 14, 7247-7269(2023).

[35] P. Illes, Y. Tang, Y. Zhang, H.-Y. Yin, P. Rubini. A possible causal involvement of neuroinflammatory, purinergic P2X7 receptors in psychiatric disorders. Curr. Neuropharmacol., 20, 2142-2155(2022).

[36] A. Rifat, B. Ossola, R. W. Bürli, L. A. Dawson, N. L. Brice, A. Rowland, M. Lizio, X. Xu, K. Page, P. Fidzinski, J. Onken, M. Holtkamp, F. L. Heppner, J. R. P. Geiger, C. Madry. Differential contribution of THIK-1 K+ channels and P2X7 receptors to ATP-mediated neuroinflammation by human microglia. J. Neuroinflammation, 21, 58(2024).